Obesity promotes alterations in iron recycling

Area of Science:

• Iron metabolism and regulation
• Obesity and its metabolic consequences

Background:

• Hepcidin is a hormone regulating iron by degrading ferroportin (FPN), which exports iron.
• Understanding how diet-induced obesity affects iron bioavailability is crucial for metabolic health.

Purpose of the Study:

• To investigate the impact of high-fat diet (HFD)-induced obesity on ferroportin (FPN) expression in macrophages and enterocytes.
• To determine if obesity alters iron bioavailability through modifications in FPN expression and localization.

Main Methods:

• Mice were fed either a control or a high-fat diet (HFD).
• Gene expression of hepcidin, DMT1, FPN, and ferritin was analyzed using real-time PCR.
• Iron levels in the liver and spleen were quantified using flame atomic absorption spectrometry.
• Ferroportin localization in macrophages was assessed via immunofluorescence microscopy.

Main Results:

• Obese mice showed increased hepcidin gene expression and iron accumulation in the spleen and liver.
• A reduction in FPN expression was observed in the liver and spleen of obese mice, with altered splenic FPN localization.
• No significant changes in FPN expression were noted in enterocytes.

Conclusions:

• Obesity, induced by HFD, alters iron bioavailability by affecting iron recycling.
• Increased hepcidin expression in obesity may be linked to elevated leptin levels, liver iron accumulation, or ER stress.